LRP5 and chronic kidney disease: Our studies presented evidence suggesting that the pro-fibrotic activity of LRP5 in the kidney is through a mechanism independent of Wnt/β-catenin signaling, which may represent a new pathogenic mechanism for the progression of renal fibrosis in CKD.